CLINICAL TRIALS PROFILE FOR LEVITRA
✉ Email this page to a colleague
All Clinical Trials for Levitra
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00377793 ↗ | Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II | Completed | Bayer | Phase 4 | 2006-07-01 | This trial is to provide additional important information on the impact of the treatment of the man its ED with vardenafil on partnership. This study is being run at up to 50 study centers in Europe and South Africa to evaluate the use of vardenafil in adult men with erectile dysfunction (often called impotence), and their female partner's sexual quality of life. Many men experience occasional erectile problems during their lives. However, when this becomes a continued problem, it can affect both the man and his female partner. The causes of erectile dysfunction are varied and may be due to physiological or emotional reasons. This study is designed to 1) study the effectiveness and safety of vardenafil, and 2) show whether treating a man its erectile dysfunction with vardenafil will improve his female partner its sexual quality of life. The second part (week 12) of the study (Educational program) a subgroup of subjects/couples, approximately 50% of the randomized subjects, will receive an educational program concerning ED in the from of a DVD. |
NCT00379756 ↗ | A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia | Completed | GlaxoSmithKline | Phase 4 | 2006-05-22 | This is a study consisting of four periods (screening, run-in, treatment, follow-up). A four-week treatment-free, run-in period where the subject will make at least four attempts at intercourse on four separate days with at least 50% of the attempts must be unsuccessful. During run-in the subjects will be using a stopwatch to measure the time from erection perceived hard enough for penetration until withdrawal from the partner's vagina. Next there are 12 weeks of treatment with either placebo or LEVITRA. Each subject will be required to visit the clinic on 5 occasions over a period of 4 months. |
NCT00443625 ↗ | Phase 1 Study of SK3530 to Investigate of the Effect of Food | Completed | SK Chemicals Co., Ltd. | Phase 1 | 2006-12-01 | This study was designed to investigate the food effect of SK3530 on the pharmacokinetics (PKs). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Levitra
Condition Name
Clinical Trial Locations for Levitra
Trials by Country
Clinical Trial Progress for Levitra
Clinical Trial Phase
Clinical Trial Sponsors for Levitra
Sponsor Name